Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. monthly Stock Chart
Amgen Inc.
IndexS&P 500 P/E16.11 EPS (ttm)12.63 Insider Own0.20% Shs Outstand607.00M Perf Week2.06%
Market Cap123.48B Forward P/E13.46 EPS next Y15.11 Insider Trans-1.01% Shs Float598.41M Perf Month15.73%
Income7.96B PEG2.93 EPS next Q3.49 Inst Own79.10% Short Float1.59% Perf Quarter18.19%
Sales23.56B P/S5.24 EPS this Y14.80% Inst Trans-3.04% Short Ratio3.09 Perf Half Y8.49%
Book/sh17.78 P/B11.44 EPS next Y5.70% ROA12.40% Target Price206.90 Perf Year3.10%
Cash/sh35.85 P/C5.67 EPS next 5Y5.51% ROE65.70% 52W Range166.30 - 211.90 Perf YTD4.49%
Dividend5.80 P/FCF22.06 EPS past 5Y13.70% ROI19.80% 52W High-5.77% Beta1.08
Dividend %2.85% Quick Ratio2.60 Sales past 5Y4.90% Gross Margin82.20% 52W Low20.06% ATR4.99
Employees21500 Current Ratio2.90 Sales Q/Q-3.10% Oper. Margin41.80% RSI (14)58.66 Volatility1.96% 2.82%
OptionableYes Debt/Eq2.84 EPS Q/Q2.70% Profit Margin33.80% Rel Volume0.68 Prev Close203.42
ShortableYes LT Debt/Eq2.58 EarningsJul 30 AMC Payout43.60% Avg Volume3.09M Price199.66
Recom2.30 SMA203.74% SMA507.65% SMA2006.89% Volume1,902,444 Change-1.85%
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-23-19 12:30PM  Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer Investor's Business Daily
10:36AM  Amgen Presents Positive Data From Rituxan Biosimilar Study Zacks
09:58AM  Alexion Stock Is Slipping Because an Amgen Bid Looks Less Likely
09:23AM  Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report Investor's Business Daily
06:00AM  A Pair of Rare Disease Biotech Concerns Worth a Good Look
Aug-22-19 01:11PM  Alexion Higher on Spanish Report, Cited by Analyst, That Amgen Will Make Bid
10:03AM  Amgen Stocks Recent Rally Will Continue. Heres Why.
09:00AM  Amgen (AMGN) Moves to Buy: Rationale Behind the Upgrade Zacks
09:00AM  Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab) PR Newswire
Aug-21-19 12:37PM  Arrowhead Pharmaceuticals: Buy at the High? Motley Fool
Aug-20-19 05:35PM  Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster Benzinga
09:44AM  Here's Why Allergan is Outperforming Its Industry Of Late Zacks
Aug-19-19 04:23PM  Why The 2 Biggest Biotech Stocks Were Just Hit With Downgrades Investor's Business Daily
01:10PM  Amgen Stocks Rally Has Come Too Far Too Fast, Analyst Says
08:04AM  AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA Zacks
07:19AM  Amgen Declines Following Mizuho Downgrade to Neutral
Aug-18-19 09:30AM  Is Amgen a Buy? Motley Fool
Aug-14-19 04:32PM  Article removed
09:36AM  Wednesdays Vital Data: Amgen, American Airlines and Apple InvestorPlace
09:35AM  Amgen (AMGN) Soars to 52-Week High, Time to Cash Out? Zacks
09:28AM  Top Ranked Income Stocks to Buy for August 14th Zacks
09:21AM  Biotech Stock Roundup: Amgen's Enbrel Patent Win, AMRN's Setback & More Zacks
08:34AM  Zacks Industry Outlook Highlights: Gilead Sciences, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals and Alexion Pharmaceuticals Zacks
Aug-13-19 04:45PM  Why This IBD Stock Of The Day Is No Longer Sweating $5 Billion In Sales Investor's Business Daily
10:48AM  Here's Why Amgen Stock is Outperforming Its Industry Of Late Zacks
10:43AM  Mergers & Acquisitions Take Center Stage in Biotech Industry Zacks
09:50AM  Should Value Investors Choose Amgen (AMGN) Stock Now? Zacks
09:30AM  Is Amgen (AMGN) Outperforming Other Medical Stocks This Year? Zacks
05:26AM  Will Amgen Continue to Surge Higher? Zacks
04:23AM  Fear Not the Curve, Sizing Up Earnings and Ways to Play Amgen: Market Recon
Aug-12-19 04:18PM  The Biggest Biotech Stock Is Approaching A Breakout Here's Why Investor's Business Daily
02:41PM  REFILE-US STOCKS-Wall Street slides on geopolitical, recession fears Reuters
02:21PM  Amgen stock gets boost from Friday ruling on Enbrel MarketWatch
01:26PM  US STOCKS-Wall Street slips on political tensions, recession fears Reuters
01:14PM  Top Analyst Reports: Amgen, Uber, Mondelez & More Zacks
11:38AM  US STOCKS-Wall Street slips on political tensions, recession fears Reuters
09:55AM  US STOCKS-Wall Street slips as trade war stokes fears of recession Reuters
09:44AM  Amgen Wins Enbrel U.S. Patent Litigation Against Novartis Zacks
09:31AM  Amgens Court Win Could Mark a New Dawn for the Stock
09:30AM  Company News For Aug 12, 2019 Zacks
09:07AM  [video]Amgen Climbs After Winning Patent Case on Enbrel
08:09AM  Top Ranked Income Stocks to Buy for August 12th Zacks
05:33AM  Amgen Rises 5%
Aug-09-19 04:48PM  US STOCKS-Wall St end down amid more trade woes, high volatility Reuters +5.95%
04:05PM  Amgen Wins Patent Case On Enbrel® (etanercept) PR Newswire
11:35AM  Amgen Rises 3%
10:31AM  Puma (PBYI) Q2 Earnings Miss, Nerlynx Sales Rise, Stock Up Zacks
07:26AM  Here's What We Like About Amgen Inc. (NASDAQ:AMGN)'s Upcoming Dividend Simply Wall St.
Aug-08-19 09:38AM  Radius (RDUS) Q2 Earnings Beat Estimates, Tymlos Sales Solid Zacks
09:26AM  Intercept (ICPT) Q2 Earnings & Sales Beat, NASH in Focus Zacks
08:34AM  Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down Zacks
Aug-07-19 04:31PM  Horizon Stock Pops On Beat And Raise As Another Drugmaker Reverses Investor's Business Daily
06:45AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-06-19 04:22PM  Biotech ETFs in Focus on Impressive Q2 Earnings Results Zacks
12:54PM  5 lsquo;Strong Buyrsquo; Dividend Stocks With High Upside Kiplinger
10:19AM  Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up Zacks
10:00AM  Looking For Growth? Take A Look At These Biotechnology Stocks Investor's Business Daily
Aug-05-19 11:23PM  Arrowhead Research Corp (ARWR) Q3 2019 Earnings Call Transcript Motley Fool
05:59PM  9 Catalysts That Will Drive Chinese Biotech Stocks Much Higher InvestorPlace
12:53PM  How Drug-Pricing Reforms Could Slam These Biotech Companies Investor's Business Daily
10:33AM  Amgen Falls 3%
09:10AM  Is Amgen (AMGN) a Great Value Stock Right Now? Zacks
Aug-04-19 03:04PM  3 Lung Cancer Stocks That Could Soar in September Motley Fool
09:26AM  [video]Amgen Changes the Narrative With Cancer Drug Breakthrough
Aug-02-19 04:00PM  Amgen Announces 2019 Third Quarter Dividend PR Newswire
Aug-01-19 12:57AM  Edited Transcript of AMGN earnings conference call or presentation 30-Jul-19 9:30pm GMT Thomson Reuters StreetEvents
Jul-31-19 04:21PM  Amgen's Biggest Moneymakers Are Struggling Will A Cancer Drug Fill In? Investor's Business Daily +5.74%
02:41PM  Amgen Gains as Cancer Drug Steals the Show From Legacy Woe Bloomberg
11:51AM  Amgen Tops Forecasters on 2nd-Quarter Earnings
11:36AM  Biotech Stock Roundup: Celgene, Amgen, Gilead Impress in Q2, Other Pipeline Updates Zacks
11:09AM  Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings? Motley Fool
10:44AM  Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat Zacks
09:34AM  Amgen (AMGN) Q2 Earnings & Sales Beat, New Drugs Shine Zacks
09:00AM  Amgens Earnings Werent a Thrill, but Promising Cancer-Drug Results Are Lifting the Stock
07:36AM  Amgen Stock Gains as Analysts Assess Solid Earnings
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
05:46AM  Amgen Rises 3%
04:25AM  Amgen Inc (AMGN) Q2 2019 Earnings Call Transcript Motley Fool
02:28AM  Apple, Federal Reserve, AMD, General Electric, Qualcomm - 5 Things You Must Know
Jul-30-19 08:40PM  Amgen Manages to Tread Water for Another Quarter Motley Fool
05:28PM  Amgen Stock Rises As Bullish Guidance Outweighs Revenue Dip Investor's Business Daily
05:15PM  Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates Zacks
04:45PM  Amgen results beat estimates, lung cancer trial planned Reuters
04:37PM  UPDATE 3-Amgen results beat estimates, lung cancer trial planned Reuters
04:09PM  Amgen shares inch up on sales, earnings beat MarketWatch
04:05PM  Amgen quarterly revenue dips 3% but profit tops Street expectations Reuters
04:01PM  Amgen Reports Second Quarter 2019 Financial Results PR Newswire
01:52PM  Gilead and Amgen will report second-quarter earnings after the closing bell. Heres what to expect MarketWatch
01:14PM  Merck Shares Rise on Strong Sales Growth
01:04PM  Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up Zacks
07:00AM  The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings Benzinga
04:06AM  Amgen boosts earnings guidance amid optimism for new cancer treatment Financial Times
Jul-29-19 03:05PM  Pfizer to Combine Off-Patent Drug Business With Mylan
10:38AM  Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up Zacks
09:18AM  Why Amgen (AMGN) Might Surprise This Earnings Season Zacks
Jul-27-19 12:20PM  10 Biggest Cancer-Fighting Stocks Motley Fool
Jul-26-19 04:00PM  Amgen Controls 98% Of The Shares In Nuevolution After The End Of The Extended Acceptance Period PR Newswire
12:06PM  What's in the Cards for Pfizer (PFE) This Earnings Season? Zacks
11:57AM  AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View Zacks
11:23AM  Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2? Zacks
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; Syapse; and DaVita Inc., as well as strategic research partnership with the University of Washington's Institute for Protein Design. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM
SUGAR RONALD DDirectorMay 01Option Exercise54.712,000109,42015,092May 03 05:37 PM
SUGAR RONALD DDirectorMay 01Sale175.732,000351,46013,092May 03 05:37 PM
SUGAR RONALD DDirectorApr 03Option Exercise54.712,000109,42015,092Apr 03 06:27 PM
SUGAR RONALD DDirectorApr 03Sale193.182,000386,36013,092Apr 03 06:27 PM
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM
SUGAR RONALD DDirectorFeb 07Option Exercise54.712,000109,42014,988Feb 11 09:27 PM
SUGAR RONALD DDirectorFeb 07Sale190.002,000380,00012,988Feb 11 09:27 PM
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM